Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization.
Cannon MV, Silljé HH, Sijbesma JW, Vreeswijk-Baudoin I, Ciapaite J, van der Sluis B, van Deursen J, Silva GJ, de Windt LJ, Gustafsson JÅ, van der Harst P, van Gilst WH, de Boer RA.
Cannon MV, et al. Among authors: de windt lj, de boer ra.
EMBO Mol Med. 2015 Sep;7(9):1229-43. doi: 10.15252/emmm.201404669.
EMBO Mol Med. 2015.
PMID: 26160456
Free PMC article.